Researchers in Prof. Minnie Sarwal's laboratory have discovered a panel of urine protein biomarkers to diagnose acute rejection in patients with kidney transplants. Acute rejection of kidney grafts remains a significant problem in transplantation community.
Many human disease conditions, such as Rheumatoid Arthritis and Type 2 diabetes, are known to have components of regulatory dysfunction as part of the genetic and biomolecular basis of their pathogenesis.
A team of Stanford researchers have identified a set of biomarkers that could be used to recognize patients with age-related declines in their immune function.
Stanford researchers have developed a method for estimating the risk for disease on a genome-wide scale while incorporating population and familial haplotype phasing.